With the recent amendments to CSR rules, a gruesome second coronavirus wave and reduced corporate performance due to the pandemic, social responsibility spend for companies is not going to be the same this fiscal
In a first in India, eight Asiatic lions have tested positive for the coronavirus. Here's what we know about the cause of Covid-19 infections in animals; limited experiments carried out in laboratories, and what the WHO recommends Covid-19 positive people
The humble oximeter has become a mainstay in every household amid the Covid-19 pandemic. A look at what the different readings mean, how they are calculated, and more
The Biden administration has come out in support of waiving intellectual property protections for coronavirus vaccines, siding with international efforts to bolster production amid concerns about vaccine access in developing nations
A small German company called CureVac is on the cusp of announcing the results of its late-stage clinical trial, and unlike the Moderna and Pfizer-BioNTech vaccine, the RNA vaccine made by CureVac doesn't need a deep freezer
A comprehensive understanding of the uptake barriers can help public health leaders and healthcare providers craft suitable communications and interventions to improve the overall testing figures
Central bank avoids announcing blanket loan moratorium as businesses appear better-equipped to operate under regional lockdowns
Playing to its strength, conserving cash, sticking to a few cities and not taking on the big players—Ola and Uber—helped the startup gain users, build trust, improve revenue and attract funding
As India reels from the second wave, and medical oxygen is running out at hospitals across the country, a look at India's oxygen requirements for Covid-19 patients versus other countries
With 1,600 staff members directing $5 billion in annual grants to 135 countries around the globe, the Gates Foundation set a new standard for private philanthropy in the 21st century
The vaccine brought in $3.5 billion in revenue in the first three months of this year, nearly a quarter of its total revenue, Pfizer reported